Information:
Fel:
ID
20057
Beskrivning
NCT01117584 Astellas Phase 2b, Double-Blind, Randomized, Multicenter, Parallel Group, Placebo-Controlled, Dose-Finding Study to Evaluate the Efficacy, Safety and Tolerability of a 12- Week Treatment with ASP1941 in Combination with Metformin in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone.
Nyckelord
Versioner (2)
- 2016-12-30 2016-12-30 -
- 2017-02-04 2017-02-04 -
Uppladdad den
4 februari 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Throughout: Metformin Intake [CM_3] NCT01117584
Throughout: Metformin Intake [CM_3] NCT01117584
- StudyEvent: ODM
Similar models
Throughout: Metformin Intake [CM_3] NCT01117584
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Metformin Brand Name
Item
Metformin Brand Name
text
C0025598 (UMLS CUI [1,1])
C0683757 (UMLS CUI [1,2])
C0683757 (UMLS CUI [1,2])
Route
Item
Route: oral
boolean
C0013153 (UMLS CUI [1,1])
C0442027 (UMLS CUI [1,2])
C0442027 (UMLS CUI [1,2])
Start Date
Item
Start Date
date
C0013216 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
Stop Date
Item
Stop Date
date
C0013216 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
Ongoing
Item
Ongoing
boolean
C0013216 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])
Total Daily Dose
Item
Total Daily Dose
text
C0013216 (UMLS CUI [1,1])
C2348070 (UMLS CUI [1,2])
C2348070 (UMLS CUI [1,2])
CL Item
once daily (1)
CL Item
twice daily (2)
CL Item
three times daily (3)
CL Item
four times daily (4)